Nasdaq:US$15.42 (-0.39) | HKEX:HK$25.40 (+0.90) | AIM:£2.36 (+0.1)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 9 Oct 2013

Chi-Med’s Pharmaceutical R&D Business – Analyst & Investor Briefing